Study to Validate a Computerized Neuropsychological Test Battery
NCT ID: NCT01421446
Last Updated: 2015-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1 participants
OBSERVATIONAL
2011-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
NCT01220674
Memory Training and Neural Plasticity
NCT05380739
Spatial Cognitive Training for Chronic Vestibular Disorders
NCT03950648
Cognitive Training and Practice Effects in Mild Cognitive Impairment
NCT02301546
Efficacy of Computerized Cognitive Training in the Elderly With Mild Cognitive Impairment
NCT03577717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Neuropsychologists are typically found in large hospitals, academic centers and in urban locations. Neuropsychologists are under represented in rural or low population centers. At the present time, cognitive assessment is frequently limited to a Mini Mental Status Examination. Furthermore, neuropsychological testing can be very expensive for patients, given insurance constraints. Finally, there is no standardized test battery that is used in different centers treating this patient population. The creation of a standard battery that could be used in other NPH centers would promote research collaboration.
A computerized neuropsychological test battery was developed in Umea, Sweden with the specific goal of using tests that are considered to be sensitive to the cognitive profile observed in NPH. The battery was developed in JAVA and Adobe Flash making it platform independent (Runs on Mac, Windows and Linux). The test battery is administered on a touch screen display, where the tests are presented through animations with audio instructions. Before the real test trails are administered, subjects are given practice trials with auditory and visual feedback. For the American version of the test, the auditory stimuli have been translated and recorded in English.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Perceptual or motor difficulties that would prevent subjects from taking the assessment
* MMSE score \<20
* MoCA score \<26
* MAS score \>9
* Significant abnormal neurologic examination findings
60 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LifeBridge Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Williams
Medical Director, Sandra and Malcolm Berman Brain & Spine Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael A Williams, MD
Role: PRINCIPAL_INVESTIGATOR
LifeBridge Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sandra and Malcolm Berman Brain & Spine Institute
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BSI-LBH 1735
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.